| Mar'20 | Mar'19 | |||||
|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||
Net loss | ||||||
-74,001 | -59,260 | |||||
Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||
Depreciation and amortization | ||||||
51,441 | 58,157 | |||||
Allowance for doubtful accounts and credit losses | ||||||
0 | 689 | |||||
Deferred income tax expense (benefit) | ||||||
4,214 | -3,946 | |||||
Share-based compensation | ||||||
16,502 | 3,176 | |||||
Deferred finance charges | ||||||
-1,008 | -2,099 | |||||
Other operating activities | ||||||
7,015 | -5,440 | |||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
-29,279 | 13,362 | |||||
Prepaid expenses | ||||||
7,349 | 9,813 | |||||
Other assets | ||||||
-54,644 | 1,507 | |||||
Accounts payable | ||||||
758 | 4,942 | |||||
Accrued expenses and other current liabilities | ||||||
-12,035 | -9,049 | |||||
Deferred revenue | ||||||
40,726 | 68,929 | |||||
Operating lease right of use assets | ||||||
-5,919 | -5,696 | |||||
Operating lease liabilities | ||||||
5,876 | 5,750 | |||||
Other liabilities | ||||||
-52,109 | -3,988 | |||||
Net cash provided by operating activities | ||||||
46,106 | 42,453 | |||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||
Capital expenditures | ||||||
19,395 | 5,957 | |||||
Acquisition, net of cash acquired | ||||||
885,323 | 0 | |||||
Proceeds from sale of product line, net of restricted cash | ||||||
3,751 | 0 | |||||
Net cash used in investing activities | ||||||
-900,967 | -5,957 | |||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||
Repayment of principal on long-term debt | ||||||
3,150 | 3,836 | |||||
Repayment of revolving credit facility | ||||||
65,000 | 30,000 | |||||
Contingent purchase price payment | ||||||
4,115 | 0 | |||||
Payment of debt issuance costs | ||||||
5,014 | 0 | |||||
Proceeds from issuance of debt | ||||||
360,000 | 0 | |||||
Proceeds from issuance of ordinary shares | ||||||
540,597 | 0 | |||||
Payments related to tax withholding for stock-based compensation | ||||||
10,420 | - | |||||
Issuance of ordinary shares, net | ||||||
278,708 | 0 | |||||
Net cash provided by (used in) financing activities | ||||||
1,091,606 | -33,836 | |||||
Effect of exchange rate changes on cash and cash equivalents, and restricted cash | ||||||
-2,013 | -190 | |||||
Net increase (decrease) in cash and cash equivalents, and restricted cash | ||||||
234,732 | 2,470 | |||||
Cash: | ||||||
Supplemental Cash Flow Information | ||||||
Cash paid for interest | ||||||
11,405 | 21,023 | |||||
Cash paid for income tax | ||||||
4,797 | 7,789 | |||||
Capital expenditures included in accounts payable | ||||||
9,528 | 6,836 | |||||